Skip to main content
NCBI home page
Molecules logoLink to Molecules
. 2013 Dec 16;18(12):15704–15716. doi: 10.3390/molecules181215704

An Efficient Approach to the Synthesis of Highly Congested 9,10-Dihydrophenanthrene-2,4-dicarbonitriles and Their Biological Evaluation as Antimicrobial Agents

Hassan M Faidallah 1,*, Khalid M A Al-Shaikh 1, Tariq R Sobahi 1, Khalid A Khan 1, Abdullah M Asiri 1,2
PMCID: PMC6270192  PMID: 24352023

Abstract

An efficient and novel method for the synthesis in moderate to good yield (72%–84%) of a series of 3-amino-1-substituted-9,10-dihydrophenanthrene-2,4-dicarbonitriles 1–5 via one-pot multi-component reactions of aldehydes, malononitrile, 1-tetralone and ammonium acetate has been delineated. Cyclocondensation attempts of aminocyanophenanthrene derivatives 1, 2, 4 and 5 with acetic anhydride in the presence of conc. H2SO4 failed and instead the diacetylamino derivatives 10–13 were obtained. All prepared compounds were structurally elucidated by various spectroscopic methods and X-ray crystallography. N,N-diacetylamino-derivatives of phenanthrene have shown good antimicrobial activity.

Keywords: dihydrophenanthrene, X-ray crystallography, dihydrobenzo[h]quinoline-3-carbonitrile, antimicrobial activity

1. Introduction

The phenanthrene moiety is a structural component of many natural products and has been linked to important roles in the pharmaceutical and biological realms. It exhibits a broad spectrum of biological activities such as antimalarial [1], anticancer [2] antimycotic [3,4] anti-HIV [5] and emetic properties [6]. C9-substituted phenanthrene-based tylophorine derivatives have shown potential antiviral activity against tobacco mosaic virus (TMV) [7]. In addition, 3,7-dihydroxy-2,4,8-trimethoxyphenanthrene is known for its anti-inflammatory properties [8], while the derivative aristolochic acid exhibits tumor-inhibitory potential [9]. The phenanthrene derivatives 3-hydroxy-2,4-dimethoxy-7,8-methylenedioxyphenanthrene and 2,7-dihydroxy-1-methyl-5-vinylphenanthrene isolated from the rhizomes of Tamus communis exhibit cytotoxicity [10,11]. 9,10-Dihydrophenantherenes with pendant carboxyl groups at position-2 are reported as inhibitors of 5α-reductase and useful in the treatment of pharmacological disorders associated with elevated levels of dihydrotestosterone [12].

Various methods have been reported for the synthesis of phenanthrenes [13] and dihydrophenanthrenes [14,15,16,17,18,19,20] through ring annulation [21], intermolecular [22] and intramolecular [23] cyclization. A majority of the procedures have certain limitations of accessibility of the precursors, require multiple steps, have harsh reaction conditions, are incompatible with the presence of functional groups, have relatively overall low yields, and lack well-defined regiocontrol elements. Phenanthrenes were prepared from disubstituted biphenyls by intramolecular condensation [22], metal-catalyzed rearrangement of alkene-alkynes [24] and cycloisomerization [25] depending on the functionality present in the biphenyl moiety. Palladium-catalyzed cyclization of arynes with alkynes is an alternative route for the synthesis of phenanthrene [24] and 9,10-disubstituted phenanthrene derivatives [26].

The diverse pharmacological activities and limitations of convenient and efficient procedures prompted us to develop a concise, straight forward and economical route to the synthesis of this class of compounds without use of any catalyst.

2. Results and Discussion

2.1. Chemistry

It has been reported [27,28] that 5,6-dihydrobenzo[h]quinoline derivatives are prepared by condensation of the corresponding 2-arylidene-1-tetralone with malononitrile in the presence of ammonium acetate or via one-pot multicomponent reactions (MCRs) of aldehydes, malononitrile, 1-tetralone and ammonium acetate. However, we found that one-pot MCRs of aldehydes, malononitrile, 1-tetralone and ammonium acetate yielded the corresponding phenanthrene derivatives instead of the expected 5,6-dihydrobenzo[h]quinolines (Scheme 1). The probable mechanism for the formation of phenanthrene derivatives is shown in Scheme 2. The structures of these phenanthrene derivatives were elucidated by analytical (Table 1) and spectroscopic data (see Experimental). The conclusive proof of the phenanthrene structure over the quinoline one was given by X-ray crystallography (Figure 1).

Scheme 1.

Scheme 1

Open in a new tab

Synthesis of Compounds 1–9.

Scheme 2.

Scheme 2

Open in a new tab

A possible mechanism of the formation of 9,10-dihydrophenanthrene-2,4-dicarbonitriles.

Table 1.

Physical and analytical data of compounds 1–13.

Compd. R Yield m.p. Mol. Formula Calc. % Found %
(%) (°C) C H N C H N
1 4-BrC₆H₄ 76 244–246 C22H14BrN3 66.01 3.53 10.50 65.98 3.64 10.45
2 4-CH3OC₆H₄ 82 214–216 C23H17N3O 78.61 4.88 11.96 78.48 4.68 11.89
3 3,4-(CH3O)2C₆H3 78 266–268 C24H19N3O2 75.57 5.02 11.02 75.62 5.16 10.87
4 3,4-(OCH2O) C₆H3 84 276–278 C23H15N3O2 75.60 4.14 11.50 75.52 4.20 11.42
5 2-Thienyl 72 220–222 C20H13N3S 73.37 4.00 12.83 73.42 3.89 12.72
6 C6H5 32 340–343 C22H15 N3 82.22 4.70 13.08 82.34 4.65 13.12
7 4-ClC₆H₄ 49 238–240 C22H14Cl N3 74.26 3.97 11.81 74.41 4.02 11.68
8 C6H5 50 290–293 C20H15 N3 80.78 5.08 14.13 80.82 5.11 14.23
9 4-ClC₆H₄ 12 222–225 C20H14Cl N3 72.40 4.25 12.66 72.36 4.32 12.61
10 4-BrC₆H₄ 82 275–277 C22H14BrN3 66.01 3.53 10.50 66.12 3.51 10.75
11 4-CH3OC₆H₄ 80 344–346 C27H21N3O3 74.47 4.86 9.65 74.61 4.68 9.55
12 3,4-(OCH2O) C₆H3 77 265–267 C27H19N3O4 72.15 4.26 9.35 72.23 4.08 9.19
13 2-Thienyl 76 355–357 C24H17N3O2S 70.05 4.16 10.21 70.12 4.22 10.31
Open in a new tab

Figure 1.

X-ray crystal structures of some dihydrophenanthrenes and dihydrobenzoquinolines.

Figure 1

a Source: reprinted from [29,30,31,32,33,34,35,36].

Open in a new tab

It is worthy to mention here that when the aromatic aldehyde is benzaldehyde, or 4-chlorobenzaldehyde two products were isolated; one is the expected benzoquinoline derivative 8 or 9 and the other is the unexpected phenanthrene 6 or 7. However, in case of the 4-chlorobenzaldehyde the major product is the phenanthrene derivative (phenanthrene/benzoquinoline 4:1) while with benzaldehyde the benzoquinoline derivative is the major product (benzoquinoline/phenanthrene 5:3).

The formation of the benzoquinoline may be explained according to the following mechanism (Scheme 3). The reaction seemed to be started by first addition of active hydrogen of 1-tetralone to the ethylenic double bond of compound A. Ammonia was added to the nitrile group in B to give C which looses a molecule of water to give D, which in turn was converted to the final product by auto-oxidation.

Scheme 3.

Scheme 3

Open in a new tab

A possible mechanism of the formation of benzoquinoline derivatives.

The IR spectra of compounds 1–9 revealed absorption bands at 3,359–3,389 cm−1 characteristic for the NH2 and at 2,318–2,226 cm−1 attributed to the CN group. Their 1H-NMR spectra exhibited, besides the aromatic protons at δ 7.17–8.02, two multiplets at δ 2.86–2.94 and 2.80–2.85 ppm corresponding to the benzylic protons (C9-H and C10-H respectively) as well as an exchangeable NH2 at δ 6.54–6.67. The structures were further supported by 13C-NMR which showed in addition to the expected number of aromatic carbons, two signals at δ 34.2–34.7 and 26.2–26.8 for the benzyl carbons (C-9 and C-10 respectively). More evidence for the structures of compounds 1–9 arise from their X-ray crystallography [29,30,31,32,33,34,35] data which confirm the phenanthrene structure for compounds 1–5 (Figure 1). However, when Ar = Ph or 4-Cl-C6H4, the X-ray crystallography confirms that they are a mixture of the benzoquinoline derivatives 6 and 7 and corresponding phenanthrene 8 and 9.

Attempts were made to prepare 2-methylpyrimidone derivative E by cyclization of the 3-aminophenanthrene derivatives 1, 2, 4 and 5 with acetic anhydride either in the presence or the absence of conc. H2SO4 adopting the same procedure reported in the literature [37,38,39,40], but these reactions afforded the N,N-diacetylaminophenanthrenes 10–13 instead of the expected pyrimidone derivatives (Scheme 4).

Scheme 4.

Scheme 4

Open in a new tab

N,N-Diacetyl derivatives of dihyrophenenthrene 10–13.

The IR spectra of compounds 10–13 were characterized by the absence of the NH2 absorption and the presence of two new sharp absorption bands in the 1,666–1,672 cm−1 region due to the new C=O groups. Their 1H NMR exhibited, besides aromatic protons at δ 7.14–7.48, two multiplets at δ 2.82–2.86 and 2.84–2.88 ppm corresponding to the H-9 and H-10 respectively, as well as a singlet of six proton intensity at δ 2.40–2.44 for the 2CH3 groups. The structures were further supported by 13C-NMR data which showed in addition to the expected number of aromatic carbons, two signals at δ 34.0–34.5 and 26.2–26.6 for C-9 and C-10 in addition to the CH3 carbons at δ 14.7–14.9. More evidence for the structure of compound 11 comes from its X-ray crystallography [36].

2.2. Biological Evaluation

2.2.1. In Vitro Antibacterial and Antifungal Activities

Compounds 1–13 were screened in vitro for their antimicrobial and antifungal activities against Escherichia coli, Staphylococcus aureus, Aspergillus niger and Candida albicans. The zones of inhibition formed for the compounds against bacteria and fungi are summarized in Table 2. The overall results suggested that compounds containing 3-(N,N-diacetylamino)-substituent exhibited relatively better antimicrobial and antifungal activities when compared with non-acetylated phenanthrene analogs thereby indicating a positive role of diacetyl-substitution in the present series. Compounds 10 and 13 were however, significantly active when compared with rest of the series. All test data in Table 2 were of average value from triplicate runs and the test compounds showed reduced antimicrobial activities when compared with their respective standards.

Table 2.

Anti-bacterial and anti-fungal data of compounds 1–13.

Compound Zone of Inhibition in mm Zone of Inhibition in mm
Escherichia coli Staphylococcus aureus Aspergillus niger Candida albicans
1 25 24 18 21
2 21 20 15 18
3 20 21 14 16
4 23 20 13 18
5 25 22 16 20
6 16 15 12 13
7 18 17 14 15
8 12 13 10 13
9 14 15 12 15
10 30 28 20 22
11 28 26 17 19
12 26 25 19 20
13 29 29 21 22
Ampicillin 30 29 - -
Clotrimazole - - 33 32
Open in a new tab

3. Experimental

3.1. General Methods

Melting points were determined on a Gallenkamp melting point apparatus and are uncorrected. The infrared (IR) spectra were recorded on Shimadzu FT-IR 8400S infrared spectrophotometer using the KBr pellet technique. 1H- and 13C-NMR spectra were recorded on a Bruker DPX-400 FT NMR spectrometer using tetramethylsilane as the internal standard and DMSO-d6 as a solvent (chemical shifts in δ, ppm). Splitting patterns were designated as follows: s: singlet; d: doublet; m: multiplet; q: quartet. Elemental analyses were performed on a 2400 Perkin Elmer Series 2 analyzer and the found values were within ±0.4% of the theoretical values. Follow up of the reactions and checking the homogeneity of the compounds were made by TLC on silica gel pre-coated aluminum sheets (Type 60 F254, Merck) and the spots were detected by exposure to UV-lamp at λ 254.

3.1.1. 3-Amino-1-substituted-9,10-dihydrophenanthrene-2,4-dicarbonitriles 1–5

A one-pot mixture of the appropriate aldehyde (10 mmol), 3,4-dihydro-2H-naphthalene-1-one (1.46 g, 10 mmol), malononitrile (0.66 g, 10 mmol) and ammonium acetate (6.2 g, 80 mmol) in absolute ethanol (50 mL) was refluxed for 6 h. The reaction mixture was allowed to cool, and the resulting precipitate was filtered, washed with water, dried and recrystallized from DMF. Yields, 72%–84%; IR: (cm−1, KBr): 3357–3361, 3420–3428 (NH2), 2220–2231 (CN).

3-Amino-1-(4-bromophenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (1): 1H-NMR (DMSO-d6) δ ppm: 2.86 (m, 2H, C-9 protons), 2.80 (m, 2H, C-10 protons), 7.12 (s, 1H, NH2), 7.24–7.48 (m, 9H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.2 (C-9), 26.3 (C-10), 116.6 (CN), 97.5, 126.2, 126.4, 127.3, 127.5, 128.6, 129.1, 129.5, 136.2, 136.7, 139.0, 145.2, 152.0 (Ar-C).

3-Amino-1-(4-methoxyphenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (2): 1H-NMR (DMSO-d6) δ ppm: 2.88 (m, 2H, C-9 protons), 2.83 (m, 2H, C-10 protons), 3.74 (CH3O), 6.98 (s, 1H, NH2), 6.85–7.49 (m, 8H, ArH). 13C-NMR (DMSO-d6) δ ppm: 33.8(C-9), 26.2 (C-10), 56.1 (CH3O), 116.5 (CN), 97.4, 114.4, 126.2, 126.6, 127.5, 128.4, 128.7, 129.4, 136.1, 139.4, 145.2, 151.8, 160.6 (Ar-C).

3-Amino-1-(3,4-dimethoxyphenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (3): 1H-NMR (DMSO-d6) δ ppm: 2.86 (m, 2H, C-9 protons), 2.82 (m, 2H, C-10 protons), 3.72 (CH3O), 3.73 (CH3O), 6.87 (s, 1H, NH2), 6.72–7.50 (m, 7H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.1 (C-9), 26.4 (C-10), 56.2 (CH3O), 56.3 (CH3O), 117.0 (CN), 97.3, 114.0, 115.5, 116.3, 120.7, 126.3, 127.4, 128.4, 129.6, 129.7, 135.9, 139.1, 145.2, 146.4, 148.2, 151.8 (Ar-C).

3-Amino-1-(benzo[d][1,3]dioxol-5-yl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (4): 1H-NMR (DMSO-d6) δ ppm: 2.87 (m, 2H, C-9 protons), 2.80 (m, 2H, C-10 protons), 5.91(CH2), 6.86 (s, 1H, NH2), 6.80–7.48 (m, 7H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.2 (C-9), 26.5 (C-10), 117.2 (CN), 91.2 (CH2), 97.5, 114.2, 115.6, 116.4, 120.7, 126.2, 127.6, 128.5, 129.4, 129.9, 136.0, 139.1, 145.3, 146.2, 148.4, 151.9 (Ar-C).

3-Amino-1-(thiophen-2-yl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (5): 1H-NMR (DMSO-d6) δ ppm: 2.89 (m, 2H, C-9 protons), 2.81 (m, 2H, C-10 protons), 6.75 (s, 1H, NH2), 6.98–7.47 (m, 7H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.3 (C-9), 26.3 (C-10), 116.9 (CN), 97.2, 98.6, 122.8, 125.2, 126.3, 127.4, 127.5, 128.3, 129.1, 136.0, 139.1, 142.4, 145.2, 151.8 (Ar-C).

3.1.2. 3-Amino-1-substituted-9,10-dihydrophenanthrene-2,4-dicarbonitriles 6 and 7 and 2-Amino-4- substituted-5,6-dihydrobenzo[h]quinoline-3-carbonitriles 8 and 9

A mixture of the 1-tetralone (1.46g, 10 mmol), the appropriate aldehyde (10 mmol), malononitrile (0.66 g, 10 mmol) and ammonium acetate (6.2 g, 80 mmol) in absolute ethanol (50 mL) was refluxed for 3–6 h. The reaction mixture was cooled and the resulting precipitate was filtered, washed with water, dried. The obtained solid was then subjected to column chromatography on silica gel (n-hexane/ethyl acetate 9:1) to give two products. IR: (cm−1, KBr): 3367–3372, 3429–3435 (NH2), 2219–2224 (CN).

3-Amino-1-phenyl-9,10-dihydrophenanthrene-2,4-dicarbonitrile (6): 1H-NMR (DMSO-d6) δ ppm: 2.86 (m, 2H, C-9 protons), 2.80 (m, 2H, C-10 protons), 7.12 (s, 1H, NH2), 7.24–7.48 (m, 9H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.2 (C-9), 26.2 (C-10), 116.6 (CN), 97.5, 126.2, 126.4, 127.3, 127.5, 128.6, 129.1, 129.5, 136.2, 136.7, 139.4, 145.2, 152.0 (Ar-C).

3-Amino-1-(4-chlorophenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (7): 1H-NMR (DMSO-d6) δ ppm: 2.84 (m, 2H, C-9 protons), 2.81 (m, 2H, C-10 protons), 7.03 (s, 1H, NH2), 7.16–7.47 (m, 9H, ArH). 13C-NMR (DMSO-d6) δ ppm: 33.3 (C-9), 26.9 (C-10), 117.4 (CN), 97.5, 126.1, 126.4, 127.0, 127.5, 128.4, 129.3, 129.6, 136.2, 137.2, 139.6, 145.4, 152.4 (Ar-C).

2-Amino-4-phenyl-5,6-dihydrobenzo[h]quinoline-3-carbonitrile (8): 1H-NMR (DMSO-d6) δ ppm: 2.56 (m, 2H, C-5 protons), 2.76 (m, 2H, C-6 protons), 6.45 (s, 1H, NH2) 7.16–7.98 (m, 9H, ArH). 13C-NMR (DMSO-d6) δ ppm: 25.2 (C-5), 28.5 (C-6), 117.0 (CN), 89.8, 125.5, 126.3, 126.8, 127.1, 128.4, 129.0, 138.2, 138.8, 139.2, 155.4, 160.6, 162.6 (Ar-C).

2-Amino-4-(4-chlorophenyl)-5,6-dihydrobenzo[h]quinoline-3-carbonitrile (9): 1H-NMR (DMSO-d6) δ ppm: 2.54 (m, 2H, C-5 protons), 2.72 (m, 2H, C-6 protons), 6.39 (s, 1H, NH2), 7.17–8.02 (m, 8H, ArH). 13C-NMR (DMSO-d6) δ ppm: 25.4 (C-5), 28.3 (C-6), 116.8 (CN), 90.0, 125.3, 126.1, 126.6, 127.1, 128.1, 129.2, 129.4, 134.3, 137.8, 138.6, 139.1, 154.4, 160.5, 162.4 (Ar-C).

3.1.3. 3-(N,N-Diacetylamino)-1-(4-bromophenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitriles 10–13

A mixture of the appropriate 3-aminophenanthrene derivative 1, 2, 4 or 5 (10.00 mmol), acetic anhydride (5 mL) and conc. H2SO4 (0.2 mL) was heated in a boiling water bath for 10 min, then cooled, poured on ice-cold water, treated with 20% NaOH solution until it reaches an alkaline pH (pH~11). The resulting solid product was filtered and recrystallized from ethanol. Yields, 76%–82%; IR: (cm−1, KBr): 2220–2228 (CN), 1692–1705 (C=O).

N-acetyl-N-(1-(4-bromophenyl)-2,4-dicyano-9,10-dihydrophenanthren-3-yl)acetamide (10): 1H-NMR (DMSO-d6) δ ppm: 2.40 (s, 6H, 2CH3), 2.88 (m, 2H, C-9 protons), 2.84 (m, 2H, C-10 protons), 7.17–7.46 (m, 9H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.2 (C-9), 26.4 (C-10), 116.8 (CN), 97.4, 126.3, 126.5, 127.3, 127.7, 128.7, 129.2, 129.8, 136.1, 136.7, 139.1, 144.6, 151.8 (Ar-C).

N-acetyl-N-(2,4-dicyano-1-(4-methoxyphenyl)-9,10-dihydrophenanthren-3-yl)acetamide (11): 1H-NMR (DMSO-d6) δ ppm: 2.88 (m, 2H, C-9 protons), 2.80 (m, 2H, C-10 protons), 3.72 (CH3O), 6.77–7.48 (m, 8H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 33.9 (C-9), 26.2 (C-10), 56.0 (CH3O), 116.7 (CN), 97.5, 114.3, 126.2, 126.4, 127.5, 128.5, 128.6, 129.6, 136.1, 139.1, 145.1, 151.9, 160.5 (Ar-C).

N-acetyl-N-(1-(benzo[d][1,3]dioxol-5-yl)-2,4-dicyano-9,10-dihydrophenanthren-3-yl)acetamide (12): 1H-NMR (DMSO-d6) δ ppm: 2.87 (m, 2H, C-9 protons), 2.82 (m, 2H, C-10 protons), 5.90 (CH2), 6.82–7.48 (m, 7H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.1 (C-9), 26.3 (C-10), 116.9 (CN), 91.2 (CH2), 97.4, 114.3, 115.5, 116.4, 120.5, 126.1, 127.5, 128.4, 129.3, 129.9, 136.0, 139.1, 145.4, 146.1, 148.3, 151.7 (Ar-C).

N-acetyl-N-(2,4-dicyano-1-(thiophen-2-yl)-9,10-dihydrophenanthren-3-yl)acetamide (13): 1H-NMR (DMSO-d6) δ ppm: 2.89 (m, 2H, C-9 protons), 2.82 (m, 2H, C-10 protons), 6.88–7.46 (m, 7H, Ar-H). 13C-NMR (DMSO-d6) δ ppm: 34.2 (C-9), 26.1 (C-10), 116.8 (CN), 97.1, 98.5, 122.6, 125.2, 126.2, 127.4, 127.6, 128.3, 129.2, 136.0, 139.1, 142.2, 145.4, 152.0 (Ar-C).

3.2. Biological Activity Evaluation

3.2.1. Anti-Microbial Activity Procedure

The preliminary anti-microbial activities of compounds 1–13 were measured in a concentration of 50 mg/L by disc diffusion method [41,42]. The prepared compounds were tested for their antimicrobial activity against Staphylococcus aureus (ATCC 25923) as Gram positive bacteria, Escherichia coli (ATCC 25922) as Gram negative bacteria, and the antifungal activity was performed using the pathogenic yeast strains Candida albicans and Aspergillus niger. DMSO was used as a solvent and the standard drugs used were ampicillin and griseofulvin. The disc diffusion method was performed using Muller-Hinton agar (Hi-Media) medium. The inhibition zones were measured in mm at the end of an incubation period of 24 h at 37 °C for bacteria and 72 h at 24 °C for fungi. The zone of inhibition in mm is expressed in Table 2. All test data in Table 2 were of average values from triplicate run.

4. Conclusions

The present paper describes an efficient and simple method for the synthesis of a series of 3-amino-1-substituted-9,10-dihydrophenanthrene-2,4-dicarbonitriles 1–5 via one-pot multicomponent reactions (MCRs). The structures of these phenanthrene derivatives were elucidated by analytical and spectroscopic data. The conclusive proof of the phenanthrene structure was given by X-ray crystallography. The prepared compounds were screened in vitro for their antimicrobial and antifungal activities. The overall results suggested that compounds containing 3-(N,N-diacetylamino)- substituent exhibited relatively better antimicrobial and antifungal activities when compared with non-acetylated phenanthrene analogs, indicating a positive role of diacetyl group in the present series. Compounds 10 and 13 were however, significantly active when compared with the rest of the series.

Acknowledgments

The authors are grateful to the Biology Department, Faculty of Science, University of Alexandria for their help in biological activity evaluation.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Sample Availability: Samples of the compounds 1–13 are available from the authors.

References

  • 1.Huffmann C.W., Traxler J.T., Krbechek L., Riter R.R., Wagner R.G. Syntheses of halogenated phenanthrene amino alcohols as antimalarials. J. Med. Chem. 1971;14:90–94. doi: 10.1021/jm00284a002. [DOI] [PubMed] [Google Scholar]
  • 2.Wilson S., Ruenitz P.C. Structural characterization and biological effects of photocyclized products of tamoxifen irradiation. J. Pharm. Sci. 1993;82:571–574. doi: 10.1002/jps.2600820605. [DOI] [PubMed] [Google Scholar]
  • 3.Fisch M.H., Flick B.H., Arditti J. Structure and antifungal activity of hircinol, loroglossol and orchinol. Phytochemistry. 1973;12:437–441. doi: 10.1016/0031-9422(73)80036-6. [DOI] [Google Scholar]
  • 4.Kelly T.R., Li Q., Bhushan V. Intramolecular biaryl coupling: Asymmetric synthesis of the chiral b-ring diol unit of pradimicinone. Tetrahedron Lett. 1990;31:161–164. doi: 10.1016/S0040-4039(00)94359-4. [DOI] [Google Scholar]
  • 5.Hoshino H., Seki J.-I., Takeuchi T. New Antifungal Antibiotics, benanomocins A and B inhibit infection of T-cell with human immunodeficiency virus (HIV) and syncytium formation by HIV. J. Antibiot. 1989;42:344–346. doi: 10.7164/antibiotics.42.344. [DOI] [PubMed] [Google Scholar]
  • 6.Cannon J.G., Khonje P.R., Long J.P. Centrally acting emetics. 9. Hofmann and Emde degradation products of nuciferine. J. Med. Chem. 1975;18:110–112. doi: 10.1021/jm00235a026. [DOI] [PubMed] [Google Scholar]
  • 7.Wang K., Hu Y., Liu Y., Mi N., Fan Z., Liu Y., Wang Q. Design, synthesis, and antiviral evaluation of phenanthrene-based tylophorine derivatives as potential antiviral agents. J. Agric. Food Chem. 2010;58:12337–12342. doi: 10.1021/jf103440s. [DOI] [PubMed] [Google Scholar]
  • 8.Bordat P., Tarroux R., Charveron M., David B. Phenanthrene Derivatives, Their Synthesis, Anti-Inflammatory Activity, and Use in Treating Inflammatory Skin Diseases. 2006089881. France Demande WO Patent. 2006
  • 9.Kupchan S.M., Wormser H.C. Tumor inhibitors. X. Photochemical synthesis of phenanthrenes. Synthesis of aristolochic acid and related compounds. J. Org. Chem. 1965;30:3792–3800. doi: 10.1021/jo01022a046. [DOI] [PubMed] [Google Scholar]
  • 10.Kovacs A., Forgo P., Zupko I., Rethy B., Falkay G., Szabo P., Hohmann J. Phenanthrenes and a dihydrophenanthrene from Tamus communisand their cytotoxic activity. Phytochemistry. 2007;68:687–691. doi: 10.1016/j.phytochem.2006.10.028. [DOI] [PubMed] [Google Scholar]
  • 11.Dellagreca M., Fiorentinob A., Isidorib M., Lavorgna M., Monaco P., Previtera L., Zarrelli A. Phenanthrenoids from the wetland Juncus acutus. Phytochemistry. 2002;60:633–638. doi: 10.1016/S0031-9422(02)00152-8. [DOI] [PubMed] [Google Scholar]
  • 12.Boger D.L., Mullican M.D. Regiospecific total synthesis of juncusol. J. Org. Chem. 1984;49:4045–4050. doi: 10.1021/jo00195a034. [DOI] [Google Scholar]
  • 13.Floyd A.J., Dyke S.F., Ward S.E. The synthesis of phenanthrenes. Chem. Rev. 1976;76:509–562. doi: 10.1021/cr60303a001. [DOI] [Google Scholar]
  • 14.Orchin M., Woolfolk E.O. Aromatic cyclodehydrogenation. I. 4-Methylfluorene from 2,2'-Dimethylbiphenyl. J. Am. Chem. Soc. 1945;67:122–124. doi: 10.1021/ja01217a040. [DOI] [Google Scholar]
  • 15.Ram V.J., Goel A. An Expeditious synthesis of 9,10-Dihydrophenanthrene by condensation of 2H-Pyran-2-ones with α-Tetralone. J. Chem. Res. (S) 1997 doi: 10.1039/A704233G. [DOI] [Google Scholar]
  • 16.Erdman H., Ronlan A. Phenol dehydrogenation. Part 11. Intramolecular oxidative coupling of dihydropiceatannol. Acta Chem. Scand. 1969;23:249–254. doi: 10.3891/acta.chem.scand.23-0249. [DOI] [Google Scholar]
  • 17.Gilchrist T.L., Summersell R.J. Synthesis of chrysenes and other a-fused phenanthrenes by a palladium(0) coupling—Electrocyclic ring closure sequence. J. Chem. Soc. Perkin Trans. 1988;1:2595–2601. doi: 10.1039/p19880002595. [DOI] [Google Scholar]
  • 18.Rabideau P.W., Marcinow Z. Silicon modified reduction and reductive alkylation-application to the phenanthrene system. Tetrahedron Lett. 1988;29:3761–3764. doi: 10.1016/S0040-4039(00)82108-5. [DOI] [Google Scholar]
  • 19.Bowden B.F., Read R.W., Ritchie E., Taylor W.C. Synthesis of 9,10-dihydrophenanthrenes including orchinol methyl ether. Aust. J. Chem. 1975;28:65–80. doi: 10.1071/CH9750065. [DOI] [Google Scholar]
  • 20.Pratap R., Ram V.J. An efficient de novo synthesis of partially reduced phenanthrenes through C−C insertion. J. Org. Chem. 2007;72:7402–7405. doi: 10.1021/jo0711079. [DOI] [PubMed] [Google Scholar]
  • 21.Catellani M., Motti E., Baratta S. A novel palladium-catalyzed synthesis of phenanthrenes from ortho-Substituted Aryl Iodides and Diphenyl- or Alkylphenylacetylenes. Org. Lett. 2001;3:3611–3614. doi: 10.1021/ol016360o. [DOI] [PubMed] [Google Scholar]
  • 22.Paredes E., Biolatto B., Kneetmann M., Mancini P. One-step synthesis of 2,9-disubstituted phenanthrenes via Diels-Alder reactions using 1,4-disubstituted naphthalenes as dienophiles. Tetrahedron Lett. 2002;43:4601–4603. doi: 10.1016/S0040-4039(02)00879-1. [DOI] [Google Scholar]
  • 23.Almedida J.F., Castedo L., Fernandez D., Neo A.G., Romero V., Tojo G. Base-induced photocyclization of 1,2-Diaryl-1-tosylethenes. A mechanistically novel approach to phenanthrenes and phenanthrenoids. Org. Lett. 2003;5:4939–4941. doi: 10.1021/ol0357954. [DOI] [PubMed] [Google Scholar]
  • 24.Katz T.J., Sivavec T.M. Metal-catalyzed rearrangement of alkene-alkynes and the stereochemistry of metallacyclobutene ring opening. J. Am. Chem. Soc. 1985;107:737–738. doi: 10.1021/ja00289a054. [DOI] [Google Scholar]
  • 25.Furstner A., Mamane V. Flexible synthesis of phenanthrenes by a PtCl2-Catalyzed cycloisomerization reaction. J. Org. Chem. 2002;67:6264–6267. doi: 10.1021/jo025962y. [DOI] [PubMed] [Google Scholar]
  • 26.Ram V.J., Nath M., Srivastava P., Sharkhel S., Maulik P.R. A facile access to the synthesis of functionalised unsymmetrical biaryls from 2H-pyran-2-ones through carbanion induced C–C bond formation. J. Chem. Soc. Perkin Trans. 2000;1:3719–3723. [Google Scholar]
  • 27.Aly A.S., El-Ezabawy S.R., Abdel-Fattah A.M. Reactions with α-substituted cinnamonitriles: Synthesis of benzo[h]quinolines and naphtho[1,2, b] pyrans. Egypt. J. Pharm. Sci. 1991;32:827–834. [Google Scholar]
  • 28.Al-Mutairi T.M., Al-Hazimi H.M., El-Baih F.E.M. One-pot multicomponent synthesis of some 5,6-dihydro-benzo[h]quinoline derivatives. J. Saudi Chem. Soc. 2009;13:199–207. doi: 10.1016/j.jscs.2009.06.001. [DOI] [Google Scholar]
  • 29.Asiri A.M., Faidallah H.M., Al-Youbi A.O., Ng S.W. 3-Amino-1-(4-bromophenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile. Acta Crystallogr. Sect. E Struct. Rep. Online. 2011;E67:o2745. doi: 10.1107/S1600536811038517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Asiri A.M., Al-Youbi A.O., Faidallah H.M., Ng S.W., Tiekink E.R.T. 3-Amino-1-(4-methoxy­phenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile. Acta Crystallogr. Sect. E Struct. Rep. Online. 2011;E67:o2449. doi: 10.1107/S1600536811033617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Asiri A.M., Al-Youbi A.O., Faidallah H.M., Ng S.W., Tiekink E.R.T. 3-Amino-1-(2H-1,3-benzodioxol-5-yl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile. Acta Crystallogr. Sect. E Struct. Rep. Online. 2011;E67:o2438. doi: 10.1107/S1600536811033563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Al-Youbi A.O., Asiri A.M., Faidallah H.M., Ng S.W., Tiekink E.R.T. 3-Amino-1-(3,4-dimethoxyphenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile. Acta Crystallogr. Sect. E Struct. Rep. Online. 2012;E68:o1027–o1028. doi: 10.1107/S1600536812010033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Asiri A.M., Faidallah H.M., Alamry K.A., Ng S.W., Tiekink E.R.T. 3-Amino-1-(3,4-dimeth­oxyphenyl)-9,10-dihydro­phenanthrene-2,4-dicarbonitrile. Acta Crystallogr. Sect. E Struct. Rep. Online. 2012;E68:o1118–o1119. doi: 10.1107/S1600536812011129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Asiri A.M., Al-Youbi A.O., Faidallah H.M., Ng S.W. 2-Amino-4-(4-chlorophenyl)-5,6-dihydrobenzo[h]quinoline-3-carbonitrile–3-amino-1-(4-chlorophenyl)-9,10-dihydrophenanthrene-2,4-dicarbonitrile (1/4) Acta Crystallogr. Sect. E Struct. Rep. Online. 2011;E67:o2874. doi: 10.1107/S1600536811040529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Asiri A.M., Al-Youbi A.O., Faidallah H.M., Ng S.W. 2-Amino-4-phenyl-5,6-dihydrobenzo-[h]quinoline-3-carbonitrile–3-amino-1-phenyl-9,10-dihydrophenanthrene-2,4-dicarbonitrile (5/3) Acta Crystallogr. Sect. E Struct. Rep. Online. 2011;E67:o2872. doi: 10.1107/S1600536811040505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Asiri A.M., Faidallah H.M., Al-Thabaiti S.A., Ng S.W., Tiekink E.R.T. N-Acetyl-N-[2,4-dicyano-1-(4-methoxyphenyl)-9,10-dihydrophenanthren-3-yl]acetamide. Acta Crystallogr. Sect. E Struct. Rep. Online. 2012;E68:o1177–o1178. doi: 10.1107/S160053681201210X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.El-Baih F.E.M. Synthesis of some Naphtho[1,2-b]Pyran, Naphtho[1,2-d]Pyrimidine and Benzo[h]Quinoline derivatives. J. Saudi Chem. Soc. 2004;8:279–288. [Google Scholar]
  • 38.El-Baih F.E.M., Al-Rasheed H.H., Al-Hazimi H.M. Synthesis of some pyridine and pyrimidine derivatives via michael-addition. J. Saudi Chem. Soc. 2006;9:575–596. [Google Scholar]
  • 39.Otto H.H., Schmelz H. Reaktionen von arylidentetralonen mit cyanessigsäurederivaten. Monatsh. Chem. 1979;110:249–256. doi: 10.1007/BF00911912. [DOI] [Google Scholar]
  • 40.Bedair A.H., El-Hady N.A., Abd El-Latif M.S., Fakery A.H., El-Agrody A.M. 4-Hydroxycoumarin in heterocyclic synthesis: Part III. Synthesis of some new pyrano[2,3-d]pyrimidine, 2-substituted[1,2,4]triazolo[1,5-c]pyrimidine and pyrimido[1,6-b][1,2,4]triazine derivatives. Il Farmaco. 2000;55:708–714. doi: 10.1016/S0014-827X(00)00097-5. [DOI] [PubMed] [Google Scholar]
  • 41.Kirkpatrick W.R., Turner T.M., Fothergill A.W., McCarthy D.I., Redding S.W., Rinaldi M.G., Patterson T.F. Fluconazole disk diffusion susceptibility testing of Candida species. J. Clin. Microbiol. 1998;36:3429–3432. doi: 10.1128/jcm.36.11.3429-3432.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Premkumar T., Govindarajan S. Antimicrobial study of pyrazine, pyrazole and imidazole carboxylic acids and their hydrazinium salts. World J. Microbiol. Biotechnol. 2005;21:479–480. doi: 10.1007/s11274-004-2041-7. [DOI] [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES